Cargando…
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
Colorectal cancer (CRC) is one of the most common neoplasms worldwide. However, the mechanisms underlying its development are still poorly understood. Thyroid hormone Receptor Interactor 13 (TRIP13) is a key mitosis regulator, and recent evidence has shown that it is an oncogene. Here, we report tha...
Autores principales: | Sheng, Nengquan, Yan, Li, Wu, Kai, You, Weiqiang, Gong, Jianfeng, Hu, Landian, Tan, Gewen, Chen, Hongqi, Wang, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852242/ https://www.ncbi.nlm.nih.gov/pubmed/29540729 http://dx.doi.org/10.1038/s41419-018-0434-z |
Ejemplares similares
-
MiR‐145 inhibits human colorectal cancer cell migration and invasion via PAK4‐dependent pathway
por: Sheng, Nengquan, et al.
Publicado: (2017) -
The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
por: You, Weiqiang, et al.
Publicado: (2019) -
Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer via Promoting c-myc Ubiquitination and Subsequent Hexokinase-2 Suppression
por: Wu, Zhenqian, et al.
Publicado: (2020) -
TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017) -
TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
por: Xue, Jiapeng, et al.
Publicado: (2023)